US will start making Bavarian Nordic's monkeypox shot

The Biden administration is aiming to ramp up supply of scarce monkeypox vaccines by clearing the way for a deal between manufacturer Bavarian Nordic and a Michigan-based company to finish packaging millions of doses in the US.

Photo: Bavarian Nordic / PR

Michigan-based Grand River Aseptic Manufacturing Inc. Grand River Aseptic Manufacturing Inc. reached a deal that would have it ready to fill Bavarian Nordic’s Jynneos vaccine into finished vials within three months, the Danish company and Biden administration officials said in a statement. The technology transfer is already underway, they said. Normally, it would take as long as eight months to get the finishing process up and running, US health officials said.

American depositary receipts of Bavarian Nordic jumped as much as 12% to USD 18.23 after Bloomberg reported that negotiations were nearly complete. Bavarian Nordic and Grand Rapids, Michigan-based Grand River didn’t respond to requests for further comment.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

FDA fast-tracks Eli Lilly's obesity candidate

Tirzepatide is already approved for type 2 diabetes, and Lilly has been vying for access to the obesity market for a while – the day the drug could be approved in both indications has now been moved up.

Jefferies spots weaknesses in GN

One potential chink in GN’s armor is that the company’s newly announced hearing aid platform, Omnia, isn’t predicted to win significant market shares.

Further reading

Related articles

Latest news

See all jobs